Application
Immunohistochemical analysis of paraffin-embedded human gastric cancer, using KIAA0196 antibody at 1:500 dilution.Application
Sample (30 ug of whole cell lysate) A: HeLa 5% SDS PAGE diluted at 1:500| Product Name | KIAA0196 antibody [C2C3], C-term |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to KIAA0196 (KIAA0196)This gene encodes a 134 kDa protein named strumpellin that is predicted to have multiple transmembrane domains and a spectrin-repeat-containing domain. This ubiquitously expressed gene has its highest expression in skeletal muscle. The protein is named for Strumpell disease; a form of hereditary spastic paraplegia (HSP). Spastic paraplegias are a diverse group of disorders in which the autosomal dominant forms are characterized by progressive, lower extremity spasticity caused by axonal degeneration in the terminal portions of the longest descending and ascending corticospinal tracts. More than 30 loci (SPG1-33) have been implicated in hereditary spastic paraplegia diseases. [provided by RefSeq] |
| Immunogen | Recombinant protein encompassing a sequence within the C-terminus region of human KIAA0196. The exact sequence is proprietary. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-P,WB |
| *Optimal dilutions/concentrations should be determined by the researcher. | |
| Species Reactivity | Human |
| Predicted Reactivity | Xenopus tropicalisXenopus tropicalis (87%) |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | MGC111053 antibody, SPG8 antibody, KIAA0196 antibody, strumpellin antibody, WASH complex subunit strumpellin antibody |
|---|---|
| Molecular Weight(MW) | 134 kDa (note) (3) |
Application
Immunohistochemical analysis of paraffin-embedded human gastric cancer, using KIAA0196 antibody at 1:500 dilution.
Application
Sample (30 ug of whole cell lysate) A: HeLa 5% SDS PAGE diluted at 1:500| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
